In The News Posted January 15, 2021 Share Posted January 15, 2021 SEATTLE, Jan. 14, 2021 /PRNewswire/ -- AltPep Corporation, a privately held biomedical company focused on diagnosing and treating Central Nervous System amyloid disorders, starting with Alzheimer's Disease, today announced it closed a $23.150 million Series A investment round. Matrix...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.